Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives

被引：36

作者：

Watson, Robert J. ^{[1
]}

Allen, Daniel R. ^{[1
]}

Birch, Helen L. ^{[1
]}

Chapman, Gayle A. ^{[1
]}

Galvin, Frances C. ^{[1
]}

Jopling, Louise A. ^{[1
]}

Knight, Roland L. ^{[1
]}

Meier, Dorica ^{[1
]}

Oliver, Kathryn ^{[1
]}

Meissner, Johannes W. G. ^{[1
]}

Owen, David A. ^{[1
]}

Thomas, Elizabeth J. ^{[1
]}

Tremayne, Nell ^{[1
]}

Williams, Sophie C. ^{[1
]}

机构：

[1] UCB Inflammat Discovery, Cambridge CB21 6GS, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 01期

关键词：

CXCR3; antagonists; piperidine urea; tropanyl urea;

D O I：

10.1016/j.bmcl.2007.10.109

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The optimization of a series of 1-aryl-3-piperidinyl urea derivatives is described in which incorporation of tropenyl and homotropenyl moieties has led to significant improvements in activity and drug-like properties. Replacement of the central piperidine with an exo-tropanyl unit led to the identification of compound 15 which provides a combination of excellent potency against human and murine receptors, drug-like properties and pharmacokinetics, thus providing a valuable tool for the evaluation of CXCR3 antagonists in models of human disease. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：147 / 151

页数：5

共 24 条

[1] A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection [J].

Akashi, S ;

Sho, M ;

Kashizuka, H ;

Hamada, K ;

Ikeda, N ;

Kuzumoto, Y ;

Tsurui, Y ;

Nomi, T ;

Mizuno, T ;

Kanehiro, H ;

Hisanaga, M ;

Ko, S ;

Nakajima, Y .

TRANSPLANTATION, 2005, 80 (03) :378-384

[2] Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists [J].

Allen, Daniel R. ;

Bolt, Amanda ;

Chapman, Gayle A. ;

Knight, Roland L. ;

Meissner, Johannes W. G. ;

Owen, David A. ;

Watson, Robert J. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (03) :697-701

[3] A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].

Baba, M ;

Nishimura, O ;

Kanzaki, N ;

Okamoto, M ;

Sawada, H ;

Iizawa, Y ;

Shiraishi, M ;

Aramaki, Y ;

Okonogi, K ;

Ogawa, Y ;

Meguro, K ;

Fujino, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703

[4] TITANIUM(IV) ISOPROPOXIDE AND SODIUM-BOROHYDRIDE - A REAGENT OF CHOICE FOR REDUCTIVE AMINATION [J].

BHATTACHARYYA, S .

TETRAHEDRON LETTERS, 1994, 35 (15) :2401-2404

[5] The role of the mast cell in the pathophysiology of asthma [J].

Bradding, P ;

Walls, AF ;

Holgate, ST .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (06) :1277-1284

[6] Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists [J].

Cole, AG ;

Stroke, IL ;

Brescia, MR ;

Simhadri, S ;

Zhang, JJ ;

Hussain, Z ;

Snider, M ;

Haskell, C ;

Ribeiro, S ;

Appell, KC ;

Henderson, I ;

Webb, ML .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) :200-203

[7] Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease [J].

Donnelly, Louise E. ;

Barnes, Peter J. .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (10) :546-553

[8] CXCR3 chemokine receptor distribution in normal and inflamed tissues:: Expression on activated lymphocytes, endothelial cells, and dendritic cells [J].

García-López, MA ;

Sánchez-Madrid, F ;

Rodríguez-Frade, JM ;

Mellado, M ;

Acevedo, A ;

García, MI ;

Albar, JP ;

Martínez-A, C ;

Marazuela, M .

LABORATORY INVESTIGATION, 2001, 81 (03) :409-418

[9] CXCR3 expression in human central nervous system diseases [J].

Goldberg, SH ;

van der Meer, P ;

Hesselgesser, J ;

Jaffer, S ;

Kolson, DL ;

Albright, AV ;

González-Scarano, F ;

Lavi, E .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2001, 27 (02) :127-138

[10] Requirement of the chemokine receptor CXCR3 for acute allograft rejection [J].

Hancock, WW ;

Lu, B ;

Gao, W ;

Csizmadia, V ;

Faia, K ;

King, JA ;

Smiley, ST ;

Ling, M ;

Gerard, NP ;

Gerard, C .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1515-1519

← 1 2 3 →